Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer

Gastrointestinal Cancer

Pembrolizumab for the treatment of gastric cancer

doi: 10.1080/14737140.

Gastrointestinal Cancer

Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments

United European Gastroenterol J.

Aguilera Munoz L, de Mestier L, Lamallem H, Jaïs B, Maire F, Lévy P, Rebours V, Hammel P

doi: 10.1177/2050640620939788.

Gastrointestinal Cancer

Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis

United European Gastroenterol J.

Iglesia D, Avci B, Kiriukova M, Panic N, Bozhychko M, Sandru V, de-Madaria E, Capurso G

doi: 10.1177/2050640620938987.

Gastrointestinal Cancer

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer

Cancer Treat Rev

Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD, Ferollà P, Herrmann K, Karamitopoulou E, Neuzillet C, Orsi F, Seppänen H, Torchio M, Valenti D, Zamboni G, Zins M, Costa A, Poortmans P

doi: 10.1016/j.ctrv.2021.102208

Pancreas Diseases

Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation

Br J Surg.

Kirkegård J, Aahlin EK, Al-Saiddi M, Bratlie SO, Coolsen M, de Haas RJ, den Dulk M, Fristrup C, Harrison EM, Mortensen MB, Nijkamp MW, Persson J, Søreide JA, Wigmore SJ, Wik T, Mortensen FV

doi: 10.1002/bjs.11093.

Gastrointestinal Cancer

Total antioxidant capacity and pancreatic cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

Cancer Epidemiol Biomarkers Prev.

Zhong GC, Pu JY, Wu YL, Yi ZJ, Wan L, Wang K, Hao FB, Zhao Y, Gong JP

doi: 10.1158/1055-9965.EPI-19-1511.

The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation

PLoS One.

Innocenti F, Owzar K, Jiang C, Etheridge AS, Gordân R, Sibley AB, Mulkey F, Niedzwiecki D, Glubb D, Neel N, Talamonti MS, Bentrem DJ, Seiser E, Yeh JJ, Van Loon K, McLeod H, Ratain MJ8, Kindler HL, Venook AP, Nakamura Y, Kubo M, Petersen GM, Bamlet WR, McWilliams RR

doi: 10.1371/journal.

Gastrointestinal CancerPancreas Diseases

Risks and Characteristics of Pancreatic Cancer and Pancreatic Relapse in Autoimmune Pancreatitis Patients

J Gastroenterol Hepatol.

Ishikawa T, Kawashima H, Ohno E, Iida T, Suzuki H, Uetsuki K, Yamada K, Yashika J, Yoshikawa M, Gibo N, Aoki T, Kataoka K, Mori H, Fujishiro M

doi: 10.1111/jgh.15163.

Hepatology

Targeted and Immune-based Therapies for Hepatocellular Carcinoma

Gastroenterology.

Greten TF, Lai CW, Li G, Staveley-O'Carroll KF

doi: 10.1053/j.gastro.

Related content

Pembrolizumab for the treatment of gastric cancer

Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments

Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer

Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation

Total antioxidant capacity and pancreatic cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation

Risks and Characteristics of Pancreatic Cancer and Pancreatic Relapse in Autoimmune Pancreatitis Patients

Targeted and Immune-based Therapies for Hepatocellular Carcinoma